黑龙江时时彩开奖时段
簡體|繁體
Introduction

Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001.
 

Essex specializes in biopharmaceutical drug development based on recombinant DNA technology. It is principally engaged in the manufacture and sale of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Group also engaged in the research and development of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects.
 

A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and three of them were classified as State-level Category I new drugs. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin.

 

时时彩大小单双口诀 快三人工精准计划软件 龙虎和的规律技巧 双色球中奖技巧 ag揭秘 大乐透阳光探码 下载牛牛游戏 后二组选每天稳赚技巧 三公手机棋牌游戏 1分快三计划软件下载 北赛车pk10直播手机版 nba赛事投注 重庆时时彩官网 极限两期平特 重庆时时计划专业计划 排列五最新49组头尾